AAAAAA
Results:
1-11
|
Results: 11
Authors:
VIGUSHIN DM
POON GK
BODDY A
ENGLISH J
HALBERT GW
PAGONIS C
JARMAN M
COOMBES RC
Citation: Dm. Vigushin et al., PHASE-I AND PHARMACOKINETIC STUDY OF D-LIMONENE IN PATIENTS WITH ADVANCED CANCER, Cancer chemotherapy and pharmacology, 42(2), 1998, pp. 111-117
Authors:
PELAH A
BODDY A
Citation: A. Pelah et A. Boddy, ADAPTIVE MODULATION OF THE MOTION AFTER-EFFECT BY WALKING, Journal of physiology, 506P, 1998, pp. 111-112
Authors:
BISOGNO G
COWIE F
BODDY A
THOMAS HD
DICK G
PINKERTON CR
Citation: G. Bisogno et al., HIGH-DOSE CYCLOSPORINE WITH ETOPOSIDE - TOXICITY AND PHARMACOKINETIC INTERACTION IN CHILDREN WITH SOLID TUMORS, British Journal of Cancer, 77(12), 1998, pp. 2304-2309
Authors:
YOUNG B
RUNGE JW
WAXMAN KS
HARRINGTON T
WILBERGER J
MUIZELAAR JP
BODDY A
KUPIEC JW
Citation: B. Young et al., EFFECTS OF PEGORGOTEIN ON NEUROLOGIC OUTCOME OF PATIENTS WITH SEVERE HEAD-INJURY - A MULTICENTER, RANDOMIZED CONTROLLED TRIAL, JAMA, the journal of the American Medical Association, 276(7), 1996, pp. 538-543
Authors:
PORTER D
BODDY A
THOMAS H
LIND M
NEWELL D
CALVERT AH
ROBSON L
BRAMPTON M
ABRAHAMSEN D
WINOGRAD B
Citation: D. Porter et al., ETOPOSIDE PHOSPHATE INFUSION WITH THERAPEUTIC DRUG-MONITORING IN COMBINATION WITH CARBOPLATIN DOSED BY AREA-UNDER-THE-CURVE - A CANCER-RESEARCH CAMPAIGN PHASE I II COMMITTEE STUDY/, Seminars in oncology, 23(6), 1996, pp. 34-44
Authors:
CALVERT AT
BODDY A
BAILEY NP
Citation: At. Calvert et al., CARBOPLATIN IN COMBINATION WITH PACLITAXEL IN ADVANCED OVARIAN-CANCER- DOSE DETERMINATION AND PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTIONS (VOL 22, PG 91, 1995), Seminars in oncology, 23(6), 1996, pp. 781-781
Authors:
ENGLISH MW
LOWIS SP
PENG B
BODDY A
NEWELL DR
PRICE L
PEARSON ADJ
Citation: Mw. English et al., PHARMACOKINETICALLY GUIDED DOSING OF CARBOPLATIN AND ETOPOSIDE DURINGPERITONEAL-DIALYSIS AND HEMODIALYSIS, British Journal of Cancer, 73(6), 1996, pp. 776-780
Authors:
WEDGE SR
LAOHAVINIJ S
TAYLOR GA
BODDY A
CALVERT AH
NEWELL DR
Citation: Sr. Wedge et al., CLINICAL PHARMACOKINETICS OF THE ANTIPURINE ANTIFOLATE (6R)-5,10-DIDEAZA-5,6,7,8-TETRAHYDROFOLIC ACID (LOMETREXOL) ADMINISTERED WITH AN ORAL FOLIC-ACID SUPPLEMENT, Clinical cancer research, 1(12), 1995, pp. 1479-1486
Authors:
CALVERT AH
BODDY A
BAILEY NP
SIDDIQUI N
HUMPHREYS A
HUGHES A
ROBSON L
GUMBRELL L
THOMAS H
CHAPMAN F
PROCTOR M
SIMMONS D
OAKEY A
LIND MJ
SINHA DV
NEWELL DR
Citation: Ah. Calvert et al., CARBOPLATIN IN COMBINATION WITH PACLITAXEL IN ADVANCED OVARIAN-CANCER- DOSE DETERMINATION AND PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTIONS, Seminars in oncology, 22(5), 1995, pp. 91-98
Authors:
BERGER BM
NAADIMUTKU A
BODDY A
FISHER HA
MCCONNELL JD
MILAM D
MOBLEY D
RAJFER J
ADAMS G
AIGEN AB
BOYD S
NARAYAN P
ANDRIOLE G
BAHNSON R
BELVILLE W
TOPLEY HM
BLOCK N
EPSTEIN HB
LAZAN DW
BAKULE PT
BOYLE ET
FERRIGNI R
BRANNAN W
BRAWER MK
FOSS F
COX CE
SMITH J
ELHILALI M
GOLDENBERG L
SULLIVAN L
NORMAN R
LAWEN JG
TRACHTENBERG J
LEPOR H
KANDZARI S
LABASKY R
KALISH M
PICKETT SH
Citation: Bm. Berger et al., THE EFFECT OF ZANOTERONE, A STEROIDAL ANDROGEN RECEPTOR ANTAGONIST, IN MEN WITH BENIGN PROSTATIC HYPERPLASIA, The Journal of urology, 154(3), 1995, pp. 1060-1064
Authors:
WYNNE HA
YELLAND C
COPE LH
BODDY A
WOODHOUSE KW
BATEMAN DN
Citation: Ha. Wynne et al., THE ASSOCIATION-OF-AGE-AND-FRAILTY WITH THE PHARMACOKINETICS AND PHARMACODYNAMICS OF METOCLOPRAMIDE, Age and ageing, 22(5), 1993, pp. 354-359
Risultati:
1-11
|